X0306 4 2019-01-08 0 0001567514 Intra-Cellular Therapies, Inc. ITCI 0001756211 Neumann Mark C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET NEW YORK NY 10016 0 1 0 0 EVP, Chief Commercial Officer Stock Option (right to buy) 12.73 2019-01-08 4 A 0 86348 0.00 A 2029-01-07 Common Stock 86348 86348 D Restricted Stock Units 2019-01-08 4 A 0 62843 0.00 A Common Stock 62843 62843 D On January 8, 2019, the reporting person was granted options to purchase 86,348 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock. On January 8, 2019, the reporting person was granted 62,843 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. /s/ Lawrence J. Hineline, Attorney-in-fact 2019-01-10